Cargando…
Development and Validation of a Gene Signature for Prediction of Relapse in Stage I Testicular Germ Cell Tumors
Background: Testicular germ cell tumors (TGCTs) are commonly diagnosed tumors in young men. However, a satisfactory approach to predict relapse of stage I TGCTs is still lacking. Therefore, this study aimed to develop a robust risk score model for stage I TGCTs. Method: RNA-sequence data of stage I...
Autores principales: | Zhou, Jian-Guo, Yang, Jie, Jin, Su-Han, Xiao, Siyu, Shi, Lei, Zhang, Ting-You, Ma, Hu, Gaipl, Udo S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412879/ https://www.ncbi.nlm.nih.gov/pubmed/32850325 http://dx.doi.org/10.3389/fonc.2020.01147 |
Ejemplares similares
-
Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma
por: Zhou, Jian-Guo, et al.
Publicado: (2019) -
Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020) -
Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
por: Lobo, João, et al.
Publicado: (2020) -
Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022) -
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
por: Christiansen, Ailsa J., et al.
Publicado: (2022)